Thio-TEPA therapy to prevent postoperative pterygium occurrence and neovascularization.
D005500:Follow-Up Studies; D006801:Humans; D009883:Ophthalmic Solutions; D011183:Postoperative Complications / Q000517:prevention & control*; D011625:Pterygium / Q000517:prevention & control / Q000532:radiotherapy / Q000601:surgery*; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use*
D009883:Ophthalmic Solutions; D013852:Thiotepa